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Abstract
BACKGROUND: One of the basic clinical indications for dynamic renal scintigraphy (DRS) is a diagnosis of obstructive 
uropathy and/or nephropathy. Currently, a basic quantitative criterion for diagnosing nephropathy is the percentage of in-
dividual kidney’s contribution in the global uptake of a radiopharmaceutical from the blood (so-called Split Function - SF). 
From a clinical point of view, a parameter evaluating a radiopharmaceutical uptake and reflecting the efficiency of a specific 
kidney, determined independently of the total uptake of both kidneys, would be much more useful. Based on a Rutland theory, 
a kidney uptake constant K proportional to a radiotracer uptake by individual kidney was introduced and applied to DRS with 
99mTc-ethylene-1-dicysteine (99mTc-EC). In addition, a kidney efficiency index (KEi) was also worked out as a new parameter 
obtained by dividing the uptake constant K by the surface of the ROI of a given kidney, which can be interpreted as the aver-
age “efficiency” of clearance of a kidney. 
MATERIAL AND METHODS: K and KEi values were verified in 72 studies selected retrospectively from patients referred 
routinely for DRS, with available current level of blood creatinine, used for calculation of estimated GFR (eGFR) according to 
a CKD-EPI formula. After splitting of eGFR values into individual kidneys according to SF, single kidney eGFR values (SKeGFR) 
were obtained and then used as a verification method for SF, K and KEi values. 
RESULTS: Correlation between SF and SKeGFR values, rsp = 0.64, was significantly weaker (p < 0.0022) than the correlation 
of SKeGFR values with K uptake constants and KEi indices: 0.90 and 0.84, respectively. 
CONCLUSIONS: Uptake constant K and KEi, as quantitative parameters, give the opportunity to analyze a function of each 
kidney separately and in an absolute way. KEi also allows for a reliable assessment of kidneys of atypical sizes (larger or smaller 
than average). It also gives the opportunity to create normative values for this parameter and may be useful in a number of 
clinical situations where the diagnostic effectiveness of such a relative parameter as SF, is severely limited, e.g. in assessing 
a large kidney with hydronephrosis or while differing a cirrhotic from hypoplastic (i.e. a small but properly functioning) kidney.
KEY words: dynamic renal scintigraphy; renal clearance; split function; uropathy; nephropathy; kidney efficiency 
index; uptake constant 
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Introduction 
In dynamic renal scintigraphy (DRS), imaging of a radiopharma-
ceutical passage through a patient’s kidneys allows the assessment 
of uptake, transport, and excretion of radiopharmaceutical by these 
organs. One of the basic clinical indications for DRS is diagnosis of 
obstructive uropathy and/or nephropathy. Persistent obstructive 
uropathy (obstruction of the urinary outflow from the calico-pelvic 
system), manifesting in DRS as a radiopharmaceutical excretion 
impairment, can lead to damage to the renal parenchyma - obstruc-
tive nephropathy, characterized by impairment of radiopharmaceuti-
cal uptake and transport function. Currently, a basic quantitative 
criterion for diagnosing nephropathy is the percentage of individual 
kidney’s contribution in the global uptake of a radiopharmaceutical 
from the blood [so-called Split Function (SF)]. In a healthy patient, 
the share of both kidneys in total radiopharmaceutical uptake 
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is similar - normal SF values are in the range between 42% and 
58% [1, 2]. 
Although the SF parameter is the basic, routinely used criterion 
for the diagnosis of nephropathy, it has its significant limitations due 
to its relative nature. The problem is manifested i.a. in cases of 
absence or only a trace function of one of kidneys (when the SF 
of the other kidney will always be close to or equal to 100%, even 
despite its damage), nephropathy of similar severity affecting both 
kidneys (both SF values remain in the normal range despite the 
disease process ongoing in both kidneys) and in case of large 
differences in the size of kidneys, e.g. hypoplasia of one of them 
(the share of SF of the smaller kidney will be significantly reduced, 
despite a normal function of nephrons). From a clinical point of 
view, a parameter evaluating a radiopharmaceutical uptake and 
reflecting the efficiency of a given kidney, determined independently 
of the total uptake of both kidneys, would be much more useful.
In 1984, Rutland [3], taking into account the method of graphic 
analysis of Patlak [4], presented a comprehensive theory ap-
plied to DRS images analysis. In his mathematical model, there 
was an uptake constant K, which he describes as “a fraction of the 
blood activity taken up per second”. This value was successfully 
applied to calculate a glomerular filtration rate (GFR) for a single 
kidney using 99mTc-DTPA [5], and in studies using 99mTc-MAG3 to 
determine tubular extraction rate (TER) [6,7]. Despite its potential 
usefulness, the Rutland method has not gained much popularity 
and has not yet been applied to a newer radiopharmaceutical 
— 99mTc-ethylene-1-dicysteine (99mTc-EC) [8].
The aim of this study was therefore to present a relatively simple 
method for generating parameters proportional to the uptake func-
tion of a single kidney, independent of the total uptake function of 
both kidneys. An additional goal was to obtain a parameter inde-
pendent of kidney size. The parameter should be useful not only in 
the situations described earlier in which SF is of limited value, but 
also, for example, in the differentiation between the cirrhotic and 
hypoplastic kidney (with normal nephron function).
Material and Methods
Material
72 patients (47 women, 25 men) aged 17-81 (average 52) 
years were qualified for the study. They were selected retrospectively 
from patients routinely referred for DRS, and the entry criterion - 
qualifying for the study group - was the available current serum 
creatinine level results in archived medical documentation, which 
enabled the determination of the approximate glomerular filtration 
rate eGFR. A total of 138 kidneys were assessed (some patients had 
only one kidney).
Study Acquisition 
DRS was performed according to a standard procedure. 
A patient was placed in the supine position with a gamma camera 
detector (GE Infinia Hawkeye 4) in the posterior projection. Image 
acquisition was started at the time of intravenous injection of 111 
MBq of 99mTc-EC. A sequence of 60 images was acquired of 20 sec-
onds each. Counts were stored in a 128 × 128 matrix. The camera 
detector, equipped with a LEHR collimator, was positioned so that 
its field of view covered — in addition to kidneys — also a heart. 
Preprocessing 
Before processing, images were smoothed twice with a typical 
filter that replaces each pixel with the average of its 3 × 3 neigh-
bourhood. An additional image was also created showing the 
summed counts from the 2 and 3 minutes of the study (parenchymal 
phase). The images prepared in this way were further processed 
using the standard and alternative — in house modified method 
for data processing.
Regions of interest (ROIs)
To determine areas of kidneys, the image presenting smoothed 
counts from the 2 and 3 minutes of the study was used. In this im-
age, an isocontour was drawn automatically extracting pixels with 
values equal to or higher than 30% of the maximum in the image 
— the ROI generated in this way, if necessary, could be corrected 
by the operator. ROI areas were also stored for use at a later pro-
cessing stage. Extra-renal background areas were determined 
automatically around the lower kidney poles.
Determining a heart ROI — whose size and correct location 
significantly affect the repeatability of final results — has been auto-
mated. An operator used an image showing the first 20 seconds of 
the study, in which he outlined (with a large margin) the heart area. 
Twenty pixels with maximum values were automatically searched in 
the outlined area — and a curve from these pixels (sum of values) 
was considered a heart curve. Examples of ROIs placement are 
shown in Figure 1.
Split Function (SF)
Software available on the Xeleris Functional Imaging Workstation 
4.0 (GE Healthcare) dedicated to dynamic renal studies was used 
for routine study processing. Split Function (SF) was determined 
from renographic curves after background subtraction, normalized 
to the areas of respective ROIs. Counts collected during radiotracer 
Figure 1. Example of heart (H), kidneys (LK, RK), and extrarenal 
background (LB, RB) ROIs
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uptake phase (from 2 to 3 min) were added (integrated) for each 
curve and then divided by the sum of counts from both kidneys. The 
result, presented in percent, was the SF value for a given kidney.
Uptake Constant K 
K uptake constants were calculated on the basis of the Rut-
land method, in which background-corrected kidney and cardiac 
curves were transformed into so-called Rutland space (Appendix). 
After transforming the curves, an uptake constant K was determined 
for each kidney. This value was calculated as an angular coef-
ficient (slope) of line, formed over a time interval between 2 and 
3 minutes of the study (from 60 to 160s). According to the theory, 
the uptake constant value is proportional to clearance function of 
the individual kidney but has no specific unit. In this paper, phrase 
“uptake index” was used for description of the graph’s axis. 
Kidney Efficiency index 
A kidney efficiency index (KEi) is a new parameter obtained 
by dividing the uptake constant K by the surface of the ROI of 
a given kidney. This parameter can be interpreted as the average 
“efficiency” of clearance of a kidney, and it has a unit marked as “up-
take index/pixel”. Such independence of clearance from a kidney 
size (in this case from its surface) opens the field for comparing 
KEi parameters between different kidneys, as well as determining 
a range of normal values, which should help determine the degree 
of impairment of kidney function. 
Single Kidney Estimated GFR (SKeGFR) 
The reliability of KEi, as an absolute index of renal function, 
was assessed by comparing its values with the estimated glo-
merular filtration rate (eGFR) values, which was calculated accord-
ing to the CKD-EPI formula [9]. This formula takes into account 
serum creatinine level as well as age, sex, and race of a patient. 
Serum creatinine levels were obtained from patients’ documenta-
tion. Testing for serum creatinine level was performed in different 
labs, but with the same, enzymatic, method. After multiplying 
eGFR values by the SF percentage values, calculated earlier for 
each kidney, a parameter determining estimated eGFR value for 
individual kidneys (Single Kidney estimated GFR — SKeGFR) 
was obtained. Unit for the SKeGFR was the same as eGFR unit, 
Figure 2. Scatter plot of Split Function (SF) and SKeGFR (rSp = 0.64) 
with regression line and its 95% confidence interval
Figure 3. Scatter plot of uptake constant K and SKeGFR (rSp = 0.90) 
with regression line and its 95% confidence interval
Figure 4. Scatter plot of KEi and SKeGFR (rSp = 0.84) with regression 
line and its 95% confidence interval
Figure 5. Scatter plot of KEi and K uptake constant (rSp = 0.94) with 
regression line and its 95% confidence interval
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which is [mL/min/1.73 m2]. SKeGFR values were compared with 
previously obtained SF parameters and K uptake constants.
Inter-observer variability 
All activities related to the study results were carried out twice, 
by different operators. Before processing, both operators underwent 
training unifying their proceedings, in particular how to determine 
ROIs. Values obtained by both operators were compared in order 
to assess the repeatability of study results.
Statistical analysis
The least squares method was used to approximate straight 
lines. Spearman’s coefficients (rsp) examined correlations between 
the SF and SKeGFR parameters, between the uptake constant K 
and SKeGFR, and between KEi parameters calculated by both 
operators.
Results 
The correlation between SF and SKeGFR values turned out 
to be statistically significant rSp = 0.64 (p < 0.0001, Fig. 2), but 
this relationship was significantly weaker (p < 0.0022) than the 
correlation of SKeGFR values with K uptake constants and KEi 
indices: 0.90 and 0.84, respectively (p < 0.0001). Figures 3 and 4 
present scatter plots of these values. Correlation between K uptake 
constants and KEi values (Fig. 5) was very high and statistically 
significant rSp = 0.94 (p < 0.0001). The repeatability of the KEi 
parameter determination by various operators turned out to be 
very high rSp = 0.986 (Fig. 6).
Discussion 
Gamma camera methods determining clearance function 
separately for each kidney were introduced in the seventies of the 
twentieth century [10, 11], and in the eighties and nineties, a meth-
odology of these studies was improved [5, 12, 13]. The method 
for clearance calculation was based on a relationship between 
a radiotracer uptake by a kidney (in per cent) and its concentration 
in blood plasma. Based on proportionality coefficients between 
these values, the clearance functions of both kidneys were esti-
mated separately. Initially, this method was used to determine only 
a glomerular filtration rate — GFR [10, 11], because 99mTc-DTPA 
was the only radiopharmaceutical labelled with radiotechnetium 
available at that time. At the beginning of the nineties, a similar 
methodology was used to estimate clearance of a newly introduced 
radiopharmaceutical — 99mTc-MAG3, secreted in renal tubules [7, 
13]. For normalization purposes, however, these methods required 
measurement of a patient’s blood sample as well as considera-
tion of a camera sensitivity while converting counts into activity. 
This was done by measuring by gamma camera a syringe with 
a radiopharmaceutical prepared for administration and a residual 
of activity in the syringe after injection. In addition, the need to ap-
ply corrections for extra-renal background, radiation absorption 
dependent on the kidney depth, radiation absorption by a couch 
and normalization of clearance values to patient body surface were 
emphasized. In subsequent versions of the methodology, the blood 
sample was no longer necessary. Clearance, expressed as a per-
centage of uptake of administered activity by kidneys, was then 
converted to clearance-specific units by using appropriate nomo-
grams [14]. However, none of these methods has been used so far 
for the radiopharmaceutical 99mTc-ethylenedicysteine (99mTc-EC) [8].
The Rutland method used in this work [3] is based on the de-
termination of a regression line between two quantities that change 
during the first 3 minutes after administration of a radiotracer, that 
is, before it begins to leave a kidney.
This applies, on one side of the equation, to the ratio of radi-
opharmaceutical uptake in a kidney, normalized to its level in the 
blood (approximated by a curve from the heart as a large reservoir of 
blood) and on the other side of the equation, to the total (integrated) 
flow of the radiopharmaceutical through the heart, also related to 
its level in blood (Appendix). In the classic Rutland method, a slope 
of a straight line of regression referred to as the “uptake index” [5], 
is proportional to the radiotracer clearance of a given kidney. It is as-
sumed in this method, that the intravascular part of the extra-renal 
background changes proportionally to the curve determined from 
above the heart as the largest blood reservoir. 
Peters [15] believes that this method has the smallest statistical 
error among other gamma camera methods used for clearance 
calculation. However, despite the fact that the possibility of using 
this method to determine the clearance of 99mTc-DTPA of each kidney 
was presented as early as in 1985, it did not find application, with 
a few exceptions [7, 16], in later works — probably due to its rela-
tively high mathematical complexity [17]. However, it has been 
mentioned in the literature, mainly in the context of calculating split 
function [1, 18], although it was not adopted in this application ei-
ther [19]. Instead, it was successfully used to generate parametric 
images of the kidneys [20–22].
Advantages of this method used to separately assess the 
function of each kidney, are significant. It is a simplified version 
of a gamma camera clearance measurement based only on 
the automated determination of areas of kidneys, heart, and the 
extra-vascular background. The fact that this method does not 
require normalization of calculated values to administered activ-
ity facilitates its application. Disregarding administered activity 
causes that parameters determining the efficiency of each kidney (K 
uptake constant and KEi index) are unnamed quantities proportional 
to their clearance function [5]. 
Figure 6. KEi values: Operator 1 and Operator 2
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In case of the KEi parameter, dividing K uptake value by the 
surface of the kidney (its ROI) made the value independent of kidney 
size. Such a quantitative parameter not only gives the opportunity 
to analyze a function of each kidney separately and in an absolute 
way, but also allows for reliable assessment of kidneys of atypical 
sizes (larger or smaller than average). It also gives the opportunity 
to create normative values for this parameter. KEi may be useful 
in a number of clinical situations where the diagnostic effective-
ness of basic parameters of dynamic renal scintigraphy, such as SF, 
is severely limited. Its absolute nature allows reliable differential 
diagnosis of uropathy and obstructive nephropathy in case of 
a single kidney or bilateral renal impairment. Its independence from 
kidney size will be important, e.g. in assessing a large kidney with 
hydronephrosis. Due to the greater initial amount of parenchyma 
of such a kidney, SF can remain within the normal range despite 
damage to some of its nephrons, while KEi will decrease already 
in the initial phase of obstructive nephropathy. A similar problem 
is met while differing a cirrhotic from hypoplastic (i.e. a small but 
properly functioning) kidney, where SF will be below the normal limit 
in both cases, while KEi will be lowered only in the kidney damaged.
The comparison of the K uptake constant (reflecting the 
clearance of individual kidney) and the KEi index with estimated 
GFR values (calculated on the basis of creatinine level, each time 
converted to individual kidney in accordance with its relative con-
tribution to radiopharmaceutical uptake) was used in this paper 
as a verification of these parameters’ usefulness in the assessment 
of renal function. 
The two presented parameters, K uptake constant and KEi 
index (Fig. 5), correlate highly with each other (0.94) but their 
meanings are slightly different. According to Rutland theory, K 
uptake constant corresponds strictly to kidney clearance, which 
is dependent on kidney size, and this is why the correlation coef-
ficient between K and SKeGFR has the highest value (0.90). KEi 
parameter, because of its average nature, corresponds more to 
kidney efficiency and is independent of kidney size. For this reason, 
correlation coefficient between KEi and SKeGFR is lower (0.84), but 
KEi still correlates strongly with kidney clearance.  
A greater spread of the K uptake constant around a regres-
sion line in patients with higher eGFR levels (Fig. 3) is caused by 
errors of eGFR values at such levels [9], i.e. due to the imperfec-
tions of the verification method. Another source of the scatter on the 
graphs (Fig. 3, 4) might be the fact that testing for serum creatinine 
level was performed in different labs, using tests from different pro-
ducers. However, higher correlation coefficients between the K and 
SKeGFR uptake constant and KEi and SKeGFR than between SF 
and SKeGFR (0.90 and 0.84 vs 0.64) indicate higher usefulness of 
those parameters in assessment of uptake function of individual 
kidneys by these values than SF. 
Due to the retrospective character of this preliminary analysis, 
it was impossible to use more accurate, measured GFR (e.g. us-
ing 99mTc-DTPA clearance) as a reference method. This will be the 
subject of a future prospective study.
The presented method ensures high repeatability mainly due 
to the high automation of data processing. The most important 
was a reproducibility of a method generating a heart curve. Us-
ing an average value of the highest 20 pixels within heart ROI 
means that shape and area under a cardiac curve remained the 
same regardless of an operator processing the study. In case of 
renal curves, an isocontour method (30% of the maximum value in 
the kidney) applied to summed images of second and third min-
utes of the study was of great importance. However, in cases when 
fragments of renal parenchyma were omitted by isocontour or when 
kidney shape was atypical — it was necessary to manually draw 
a fragment or the entire kidney ROI.
The method also avoids errors introduced by the need to meas-
ure the administered activity. Thanks to this, even a paravenous in-
jection should not affect negatively the quantitative parameters of 
kidney function. 
Our method also assumes, as demonstrated by Rehling et al. 
[5], that the absorption of radiation emitted by kidneys is similar 
to the absorption of radiation coming from the heart (these ef-
fects cancel each other out), hence it is not necessary to apply 
corrections accounting for the absorption of radiation. As Rehling 
et al. showed, these corrections can be omitted, especially in the 
light of the fact that differences in the depth of the kidneys in patient 
in the lying position, exceeding 1 cm, are relatively rare [23].
Conclusions
A method of calculating the uptake constant K (value pro-
portional to kidney clearance) presented here in application to 
99mTc-EC, due to its high degree of automation, is characterized 
by high repeatability. In clinical situations where the classic pa-
rameters of dynamic renal scintigraphy are unreliable, the use of 
the KEi parameter (average clearance per pixel) should improve 
the diagnostic effectiveness of this study, including differential 
diagnosis of uropathy and obstructive nephropathy or cirrhotic 
and hypoplastic kidney.
Appendix
Rutland space — a space described by variables created on 
renographic and cardiac curves. At the initial stage of the renoscin-
tigraphic examination (2–3 minutes of the study), the distribution 
of points in this space is approximated by a straight line described 
by the equation:
                                                            (E1) 
where: 
R(t) — kidney (renographic) curve after background subtraction 
H(t) — cardiac curve. The author’s modification of the method 
uses of a sum of 20 pixels with maximum values within the heart ROI,
F — blood background subtraction factor, 
K — uptake constant, fraction of blood activity taken up per time 
unit — can be calculated as a slope of the straight line described 
by equation E1. This value reflects the clearance of individual kid-
neys and is dependent on kidney size. After dividing this value by 
kidney ROI area, the KEi parameter was obtained, reflecting the 
average efficiency of the kidney in filtering blood.
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